Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions
Jennifer R. Gamble(University of Adelaide), Mathew A. Vadas(Commonwealth Scientific and Industrial Research Organisation), Jenny Drew(Commonwealth Scientific and Industrial Research Organisation), Anne Underwood(Commonwealth Scientific and Industrial Research Organisation), George D. Yancopoulos(Regeneron (United States)), John S. Rudge(Regeneron (United States)), Michelle Parsons(Commonwealth Scientific and Industrial Research Organisation), Lisa Kasminkas(Commonwealth Scientific and Industrial Research Organisation), Libby Trezise(Commonwealth Scientific and Industrial Research Organisation)
Cited by 499
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k